Related Experiment Videos

Why do all drugs work in animals but none in stroke patients? 2. Neuroprotective therapy

¹Department of Neurology, University of Texas Medical School at Houston.

Journal of Internal Medicine

|January 1, 1995

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Treatment of adult moyamoya disease by encephalo-duro-arterio-synangiosis: Five case reports.

Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association·2015

Does the cognitive measure Cog-4 show improvement among patients treated with thrombolysis after acute stroke?

International journal of stroke : official journal of the International Stroke Society·2012

Combination Therapy Stroke Trial: recombinant tissue-type plasminogen activator with/without lubeluzole.

Cerebrovascular diseases (Basel, Switzerland)·2001

Lubeluzole in acute ischemic stroke treatment: A double-blind study with an 8-hour inclusion window comparing a 10-mg daily dose of lubeluzole with placebo.

Stroke·2000

Finding the most powerful measures of the effectiveness of tissue plasminogen activator in the NINDS tPA stroke trial.

Stroke·2000

Combined intravenous and intra-arterial r-TPA versus intra-arterial therapy of acute ischemic stroke: Emergency Management of Stroke (EMS) Bridging Trial.

Stroke·1999

See all related articles